Ms Andrea Reid > Dechert LLP > Boston, United States > Lawyer Profile

Dechert LLP
BOSTON, MA 02110-2605
United States
Andrea Reid photo

Work Department

Intellectual Property


Andrea L.C. Reid, co-lead of Dechert’s Global Life Sciences Practice, counsels established and start-up clients in all sectors of the biotech and pharmaceutical industries on developing intellectual property issues, policies, patent portfolio management and filing strategies at all phases of the business cycle. Ms. Reid’s ability to develop IP strategies for U.S. and European clients has resulted in more than US$10 billion in acquisition and investor/partner funding. With more than 30 years of experience working in the pharmaceutical industry, she has extensive experience in all areas of drug discovery through drug development. She draws on this experience when prosecuting patent applications and preparing patentability, validity and infringement opinions involving active pharmaceutical ingredients, manufacturing syntheses and formulations. She regularly represents clients on specialty issues relating to organic chemistry, small molecule pharmaceuticals and polymorph intellectual property.


Boston University, B.S., Chemistry, 1987 University of Massachusetts Lowell, M.S., Chemistry, 1996 Suffolk University Law School, J.D., Intellectual Property, 2006, with distinction

Lawyer Rankings

United States > Healthcare > Life sciences

Regarded by some clients as ‘easily the best’, Dechert LLP’s global life sciences practice often handles patent and IP litigations, contentious antitrust matters, and product liability related issues. Working with a host of start-ups and mature pharmaceutical and biotech companies, Andrea Reid co-heads the team from Boston, drawing on her expertise in IP strategy and prosecution. Based in New York, the ‘truly exceptional‘ fellow co-chair David S Rosenthal maintains a corporate finance and life sciences M&A focused practice. Rosenthal routinely advises public and private investment banks and venture capital firms on IPOs and CMPOs looking to invest in life sciences and medical device companies. Also based in New York, Katherine Helm notably acts for biotech and pharmaceutical companies in biologics patent disputes before the PTAB.

United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)

Dechert LLP‘s Boston-based practice is co-led by Andrea Reid and Andrew Wilkins, who is described as ‘one of the best IP counsel’. The team is adept at advising on prosecution in a multitude of areas, though there is an evident expertise across the board in biotech, with the team being noted as a ‘terrific partner when it comes to new technologies’. Additionally, its work in life sciences and pharmaceuticals is noteworthy, a key example being Reid and the ‘business-centric’ and ‘excellent’ Chad Davis representing AVEO Oncology on the $566m multi-jurisdictional creation of its patent portfolio following its acquisition by LG Chem. Scott Warren  left the firm in August 2022.